N
Nariman F. Salakhutdinov
Researcher at Russian Academy of Sciences
Publications - 394
Citations - 4121
Nariman F. Salakhutdinov is an academic researcher from Russian Academy of Sciences. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 27, co-authored 340 publications receiving 3036 citations. Previous affiliations of Nariman F. Salakhutdinov include Novosibirsk State University.
Papers
More filters
Journal ArticleDOI
Synthesis of Optically Active Tricyclic Ethers by Reactions of (−)‐β‐Pinene with Phenols in Organized Media
Journal ArticleDOI
A highly effective antiparkinsonian drug of a new structural type.
T. G. Tolstikova,Alla Pavlova,Ye. A. Morozova,O. V. Ardashov,Irina V. Il'ina,Konstantin P. Volcho,Nariman F. Salakhutdinov,Tolstikov Genrikh A +7 more
Journal ArticleDOI
Quantitative HPLC determination of main flavonoid content of Rhododendron adamsii leaves and stems.
Nina I. Komarova,Artem D. Rogachev,E. I. Chernyak,S. V. Morozov,V. V. Fomenko,Nariman F. Salakhutdinov +5 more
TL;DR: The content of main flavonoids from Rhododendron adamsii R. leaves and stems was determined quantitatively using HPLC as discussed by the authors, and it was found that myricetin and quercetin dominated the identified compounds.
Journal ArticleDOI
Dual Effect of Soloxolone Methyl on LPS-Induced Inflammation In Vitro and In Vivo.
Andrey V. Markov,Aleksandra V Sen'kova,Valeriya O. Babich,Kirill V Odarenko,Vadim A Talyshev,Oksana V. Salomatina,Nariman F. Salakhutdinov,Marina A. Zenkova,Evgeniya B. Logashenko +8 more
TL;DR: Surprisingly, it was found that SM significantly enhanced LPS-induced expression of the pro-inflammatory cytokines interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α), and interleUKin-1β (IL -1β) in RAW264.7 cells via activation of the c-Jun/Toll-like receptor 4 (TLR4) signaling axis.
Journal ArticleDOI
Study of cholesterol-lowering effect and safety of simvaglisin on rabbit model of hypercholesterolemia.
Yu. I. Ragino,V. A. Vavilin,Nariman F. Salakhutdinov,S. I. Makarova,E. M. Stakhneva,O. G. Safronova,Yu. P. Nikitin,G. A. Tolstikov +7 more
TL;DR: Using rabbit model of experimental hypercholesterolemia, it is shown that the hypocholesterolemic effect of simvaglisin, a complex preparation containing simvastatin and glycyrrhizic acid, in doses corresponding to 40, 66.5, and 100 mg/kg/day simVastatin is equal to the Hypocholesterolesmia effect of 200 mg/ kg/ day simvastsatin alone.